Latest filing published 30 Sept 2026 for Liberty Star Uranium & Metals CORP., €3,433.
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Pete O'Heeron across 2 companies, led by Liberty Star Uranium & Metals Corp. and FibroBiologics, Inc. Between 12 August 2014 and 28 September 2026, the trades on record add up to 31 filings.
Purchases make up the whole of the open-market record (26 purchases, €1.8M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants. In 2026 alone, the filings show 4 purchases and no sales.
Half of the purchases are above €12k and half below. Clusters matter here: 7 out of 22 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 13% of cases; the median change was -28.2%. These figures describe past trades and do not predict future prices.
The latest filing, published on 30 September 2026, reports an open-market purchase of €3,433 in Liberty Star Uranium & Metals Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations